Location: Southeast USA (South Carolina)
Industry: Pharmaceutical CDMO | Peptide Manufacturing
Position: Managing Director & Site Head
Employment: Full-time | Site-based
The Opportunity
Hartmann Young is partnering with an established global pharmaceutical CDMO to appoint a Managing Director & Site Head for a US peptide manufacturing operation undergoing significant expansion.
This is a senior executive leadership opportunity with full responsibility for site operations, financial performance, organisational development and the operational readiness of a new peptide manufacturing facility.
The successful candidate will lead an established manufacturing operation while developing the infrastructure, leadership team and operational capabilities required to support future growth.
This role would suit an experienced Site Head, General Manager or Managing Director with a strong background in peptide manufacturing, regulated pharmaceutical operations and large-scale facility expansion.
Key Responsibilities
- Provide strategic and operational leadership across the manufacturing site, ensuring safe, compliant and commercially sustainable operations.
- Develop and execute a multi-year site growth strategy aligned with manufacturing capacity, customer demand and business objectives.
- Lead the operational readiness and startup of a new peptide manufacturing facility, including staffing, training, systems, processes and infrastructure.
- Oversee site financial performance, including P&L accountability, operational budgets, forecasting and cost management.
- Drive operational excellence, manufacturing efficiency, asset utilisation and continuous improvement.
- Lead organisational development, including building the site leadership team, workforce planning, talent acquisition and succession planning.
- Oversee peptide technology transfer, process scale-up and manufacturing readiness in collaboration with technical development, MSAT, engineering and quality teams.
- Work closely with capital project leadership on facility design, commissioning, qualification, validation and operational handover.
- Ensure compliance with cGMP, FDA, ICH, EHS and applicable process safety requirements.
- Lead the integration and alignment of existing manufacturing operations with new facilities, systems and organisational structures.
- Collaborate with commercial leadership on capacity planning, customer commitments and sustainable profitability.
- Represent the site with customers, regulatory authorities and senior corporate stakeholders.
Candidate Requirements
- Degree in Chemistry, Chemical Engineering or a related technical discipline; advanced degree advantageous.
- 10+ years of progressive leadership experience within pharmaceutical, chemical or CDMO manufacturing environments.
- Strong peptide manufacturing experience , ideally within a CDMO or commercial API manufacturing environment.
- Proven experience leading complex manufacturing operations with significant operational and financial accountability.
- Demonstrated responsibility for site P&L, budgets, operational performance and strategic planning.
- Experience supporting major capital expansions, facility startups, commissioning, qualification and validation.
- Strong understanding of peptide technology transfer, process scale-up and manufacturing operations.
- Working knowledge of cGMP, FDA, ICH and relevant environmental and process safety regulations.
- Demonstrated ability to build high-performing leadership teams and manage organisational change.
- Strong executive communication, stakeholder management and strategic decision-making capabilities.
Why Consider This Opportunity?
This is an opportunity to lead a growing US peptide manufacturing operation at a pivotal stage of its development.
The incoming Managing Director will have significant influence over the site's long-term direction, combining leadership of existing operations with responsibility for building the team, systems and capabilities required for a major manufacturing expansion.
The position offers substantial strategic visibility within an international CDMO organisation and the opportunity to play a central role in expanding peptide manufacturing capabilities.
#J-18808-Ljbffr